Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/24405
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2022-02-10T11:11:51Z | - |
dc.date.available | 2022-02-10T11:11:51Z | - |
dc.date.issued | 2010-02 | - |
dc.identifier.citation | Evci, C. vd. (2010). "Comparative evaluation of the antifungal susceptibility of Candida isolates from blood specimens: Results of a study in a tertiary care hospital in Bursa, Turkey". Turkish Journal of Medical Sciences, 40(1), 141-149. | tr_TR |
dc.identifier.issn | 1300-0144 | - |
dc.identifier.uri | https://doi.org/10.3906/sag-0808-14 | - |
dc.identifier.uri | https://journals.tubitak.gov.tr/medical/issues/sag-10-40-1/sag-40-1-22-0808-14.pdf | - |
dc.identifier.uri | http://hdl.handle.net/11452/24405 | - |
dc.description.abstract | Aim: Antifungal susceptibility testing may be an important aid in the treatment of patients with life threatening yeast infections. The aim of this study was to determine the susceptibility of Candida isolates obtained from clinical specimens to the antifungal agents amphotericin B and fluconazole, which are frequently used in our clinical practice. Materials and methods: Susceptibility to antifungal agents was investigated using the Etest (AB Biodisk, Solna, Sweden) and the reference broth macrodilution susceptibility test (CLSI M27-A2). The MICs obtained with each of the methods were read after 24 h and 48 h of incubation. Results: Overall agreement rates within +/- 1 dilution between the 2 methods were 86.7% (24 h) and 94.1% (48 h) for amphotericin B, and 85.5% (24 h) and 73.3% (48 h) for fluconazole. All C. albicans, C. pelliculosa, C. glabrata, and C. kefyr isolates were inhibited by <= 1 mu g mL-1 of amphotericin B, and fluconazole resistance was not observed in C. albicans or C. tropicalis isolates according to the 2 methods. Conclusion: According to the results of this study, decreased susceptibility to fluconazole and amphotericin B was most prominent in C. parapsilosis, C. krusei, and C. glabrata isolates. | en_US |
dc.description.abstract | Amaç: Antifungal duyarlılık testleri, yaşamı tehdit eden maya mantarı enfeksiyonu olan hastaların tedavisinde büyük önem taşımaktadır. Bu çalışmanın amacı klinik örneklerden soyutlanan Candida kökenlerinin pratik uygulamada sıklıkla kullanılan antifungal ilaçlar olan amfoterisin B ve flukonazole duyarlılıklarının belirlenmesidir. Yöntem ve gereç: Antifungal ilaçlara duyarlılık, Etest (AB Biodisk, Solna, İsveç) ve referans broth makrodilüsyon duyarlılık testi (CLSI M27-A2) ile araştırıldı. MİK değerleri, her iki yöntem ile 24 ve 48 saatlik inkübasyonun sonunda değerlendirildi. Bulgular: İki yöntem arasında (±) 1 dilüsyon içinde uyum oranları, amfoterisin B için % 86,7 (24 saat) ve % 94,1 (48 saat), flukonazol için % 85,5 (24 saat) ve % 73,3 (48 saat) idi. C. albicans, C. pelliculosa, C. glabrata ve C. kefyr kökenlerinin tümü, ≤1 μg mL−1 konsantrasyonda amfoterisin B ile inhibe oldu ve C. albicans ya da C. tropicalis kökenlerinde her iki yöntem ile flukonazole direnç saptanmadı. Sonuç: Bu çalışmada, flukonazol ve amfoterisin B’ye duyarlılığın azalması, en belirgin olarak C. parapsilosis, C. krusei ve C. glabrata kökenlerinde görüldü. | tr_TR |
dc.language.iso | en | en_US |
dc.publisher | TÜBİTAK | tr_TR |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.rights | Atıf Gayri Ticari Türetilemez 4.0 Uluslararası | tr_TR |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject | Candida species | en_US |
dc.subject | Antifungal susceptibility tests | en_US |
dc.subject | Antimicrobial surveillance program | en_US |
dc.subject | Amphotericin-B | en_US |
dc.subject | Broth microdilution | en_US |
dc.subject | National-committee | en_US |
dc.subject | Stream infections | en_US |
dc.subject | Etest method | en_US |
dc.subject | Fluconazole | en_US |
dc.subject | Voriconazole | en_US |
dc.subject | Trends | en_US |
dc.subject | Macrodilution | en_US |
dc.subject | General & internal medicine | en_US |
dc.subject | Albicans | en_US |
dc.subject | Antifungal agents | en_US |
dc.subject | Antifungal susceptibility | en_US |
dc.subject | Antifungal susceptibility testing | en_US |
dc.subject | Blood specimens | en_US |
dc.subject | Candida species | en_US |
dc.subject | Clinical practices | en_US |
dc.subject | Comparative evaluations | en_US |
dc.subject | Fluconazole | en_US |
dc.subject | Kefyr | en_US |
dc.subject | Susceptibility tests | en_US |
dc.subject | Fungicides | en_US |
dc.subject | Candida türleri | tr_TR |
dc.subject | Antifungal duyarlılık testleri | tr_TR |
dc.title | Comparative evaluation of the antifungal susceptibility of Candida isolates from blood specimens: Results of a study in a tertiary care hospital in Bursa, Turkey | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000275833900022 | tr_TR |
dc.identifier.scopus | 2-s2.0-76149105159 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Mikrobiyoloji Anabilim Dalı. | tr_TR |
dc.contributor.orcid | 0000-0002-4803-8206 | tr_TR |
dc.contributor.orcid | 0000-0002-4759-9634 | tr_TR |
dc.identifier.startpage | 141 | tr_TR |
dc.identifier.endpage | 149 | tr_TR |
dc.identifier.volume | 40 | tr_TR |
dc.identifier.issue | 1 | tr_TR |
dc.relation.journal | Turkish Journal of Medical Sciences | en_US |
dc.contributor.buuauthor | Evci, Canan | - |
dc.contributor.buuauthor | Ener, Beyza | - |
dc.contributor.buuauthor | Göral, Güher | - |
dc.contributor.buuauthor | Akçağlar, Sevim | - |
dc.contributor.researcherid | AAG-8523-2021 | tr_TR |
dc.indexed.trdizin | Trdizin | tr_TR |
dc.subject.wos | Medicine, general & internal | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.wos.quartile | Q4 | en_US |
dc.contributor.scopusid | 22034011200 | tr_TR |
dc.contributor.scopusid | 15053025300 | tr_TR |
dc.contributor.scopusid | 6603453166 | tr_TR |
dc.contributor.scopusid | 6506194958 | tr_TR |
dc.subject.scopus | Candidemia; Invasive Candidiasis; Candida Parapsilosis | en_US |
dc.subject.emtree | Amphotericin B | en_US |
dc.subject.emtree | Fluconazole | en_US |
dc.subject.emtree | Antifungal resistance | en_US |
dc.subject.emtree | Antifungal susceptibility | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Blood sampling | en_US |
dc.subject.emtree | Broth dilution | en_US |
dc.subject.emtree | Candida | en_US |
dc.subject.emtree | Candida albicans | en_US |
dc.subject.emtree | Candida glabrata | en_US |
dc.subject.emtree | Candida krusei | en_US |
dc.subject.emtree | Candida parapsilosis | en_US |
dc.subject.emtree | Candida tropicalis | en_US |
dc.subject.emtree | Candida zeylanoides | en_US |
dc.subject.emtree | Clinical evaluation | en_US |
dc.subject.emtree | Clinical practice | en_US |
dc.subject.emtree | Comparative study | en_US |
dc.subject.emtree | Fungus culture | en_US |
dc.subject.emtree | Fungus isolation | en_US |
dc.subject.emtree | Incubation time | en_US |
dc.subject.emtree | Kluyveromyces marxianus | en_US |
dc.subject.emtree | Minimum inhibitory concentration | en_US |
dc.subject.emtree | Nonhuman | en_US |
dc.subject.emtree | Pichia anomala | en_US |
dc.subject.emtree | Tertiary health care | en_US |
dc.subject.emtree | Turkey (bird) | en_US |
Appears in Collections: | Scopus TrDizin Web of Science |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Evci_vd_2010.pdf | 117.97 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License